CVS Health (CVS) – Investment Analysts’ Recent Ratings Updates

CVS Health (NYSE: CVS) recently received a number of ratings updates from brokerages and research firms:

• 8/19/2026 – CVS Health had its price target raised by Argus from $104.00 to $114.00. They now have a “buy” rating on the stock.
• 8/12/2026 – CVS Health had its price target raised by JPMorgan Chase & Co. from $111.00 to $118.00. They now have an “overweight” rating on the stock.
• 8/8/2026 – CVS Health was upgraded by Wall Street Zen from “buy” to “strong-buy”.
• 8/6/2026 – CVS Health was given a new $107.00 price target by Robert W. Baird.
• 8/6/2026 – CVS Health had its price target raised by UBS Group AG from $122.00 to $126.00. They now have a “buy” rating on the stock.
• 8/6/2026 – CVS Health had its price target raised by Barclays PLC from $106.00 to $108.00. They now have an “overweight” rating on the stock.
• 8/5/2026 – CVS Health was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.
• 7/24/2026 – CVS Health had its price target raised by UBS Group AG from $115.00 to $122.00. They now have a “buy” rating on the stock.
• 7/23/2026 – CVS Health was upgraded by Wall Street Zen from “hold” to “buy”.
• 7/20/2026 – CVS Health was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
• 7/15/2026 – CVS Health was downgraded by Wall Street Zen from “buy” to “hold”.
• 7/14/2026 – CVS Health had its price target raised by Truist Financial Corporation from $108.00 to $118.00. They now have a “buy” rating on the stock.
• 7/13/2026 – CVS Health had its price target raised by Wells Fargo & Company from $103.00 to $123.00. They now have an “overweight” rating on the stock.
• 7/9/2026 – CVS Health had its price target raised by Royal Bank Of Canada from $107.00 to $113.00. They now have an “outperform” rating on the stock.
• 7/7/2026 – CVS Health was upgraded by Wall Street Zen from “hold” to “buy”.
• 7/7/2026 – CVS Health had its price target raised by Cantor Fitzgerald from $100.00 to $110.00. They now have an “overweight” rating on the stock.
• 7/6/2026 – CVS Health had its “hold” rating reaffirmed by HSBC Holdings plc. They now have a $103.00 price target on the stock.
• 6/29/2026 – CVS Health was downgraded by Wall Street Zen from “buy” to “hold”.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.9%. CVS Health’s dividend payout ratio is 70.37%.

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.